Autres langues AstraZeneca PLC Nasdaq Stockholm

Actions

AZN

GB0009895292

Produits pharmaceutiques

Marché Fermé - Nasdaq Stockholm 18:00:00 12/08/2026			Varia. 5j.	Varia. 1 janv.
1 507,50 ^SEK	-1,41%		-0,20%	-11,51%

17:43	Octave chute après ses résultats, l'indice OMXS30 recule de 0,2 %	FW
16:13	Chine : approbation pour le traitement du cancer du sein d'AstraZeneca et Daiichi Sankyo	MT

Autres langues

16:13	AstraZeneca, Daiichi Sankyo's Breast Cancer Drug Combo Gets Approval in China
15:55	AstraZeneca, Daiichi Sankyo's Breast Cancer Drug Combo Gets Approval in China
15:29	Daiichi, AstraZeneca drug Enhertu wins further approval in China
14:55	A No to BMS can open doors for a Yes to GSK
11/08	Global drugmakers invest billions to boost US presence
10/08	Lupin Gets FDA Approval for Hyperkalemia Drug
10/08	LSE-Vize : Londoner Börse braucht Kapital für Aufschwung
07/08	Jefferies belässt Astrazeneca auf 'Buy' - Ziel 17500 Pence
06/08	Blue chips fall but FTSE 250 extends winning run
06/08	Morning Meeting: El oro despierta y los chips sufren una corrección
06/08	Morning Meeting: Die Märkte gleiten langsam in die Sommerflaute
06/08	Markets Drift Gently Towards the Mid-August Lull
06/08	US FDA approves first mRNA flu shot from Moderna
06/08	AstraZeneca, Jaguar Land Rover Gain Access to UK's Fast-Track Visa
05/08	AstraZeneca Is Said to Have Explored Bristol Myers Merger
05/08	FTSE 100 rises, led by Glencore, Next earnings; banks slide
05/08	AstraZeneca, Bristol Myers Not Pursuing Merger Talks
05/08	European Stocks Close Mostly Higher in Wednesday Trading as Investors Monitor Middle East Developments
05/08	European Equities Traded in the US as American Depositary Receipts Edge Up in Wednesday Trading
05/08	INTERVIEW/Novo-Nordisk-CEO offen für ergänzende Übernahmen
05/08	AstraZeneca, Bristol Myers Not Pursuing Merger Talks
05/08	AstraZeneca Pays CSPC $10 Million for Exercise of License Option for Pre-clinical Candidate Program
05/08	AstraZeneca, Bristol Myers Squibb Reportedly Not Discussing Merger
05/08	AstraZeneca, CSPC Pharmaceutical Group Form JV for Biologics Manufacturing Facility in China
05/08	"No hay conversaciones" sobre acuerdo entre AstraZeneca y Bristol Myers: fuente